DOC Generici pharmaceutical products

DOC Generici is a major Italian pharmaceutical company founded in 1996, specifically focused on the generic medicines market following the expiration of drug patents. It has grown to be one of the largest players in the Italian generic drugs sector, providing a wide range of therapeutic treatments.

While the brand originated in Italy and remains headquartered in Milan, its ownership has transitioned through several private equity firms over the years. Currently, the company is owned by a consortium led by TPG Capital and ICG (Intermediate Capital Group), which acquired it from CVC Capital Partners. The manufacturing process often involves a network of high-quality contract manufacturing organizations across Italy and the European Union to ensure compliance with strict pharmaceutical standards.